When was the last time you heard of a Chinese pharmaceutical company with a novel, non-generic product?
Sure, the Chinese make existing drugs and APIs. They're probably the world leaders in generic peptide production. They also do a lot of basic research. What is lacking -- what is proportionately small -- is their share of innovative new drugs developed. This is slowly changing, but the Chinese are way behind in drug development and commercialization. That's what I meant.
Sure, the Chinese make existing drugs and APIs. They're probably the world leaders in generic peptide production. They also do a lot of basic research. What is lacking -- what is proportionately small -- is their share of innovative new drugs developed. This is slowly changing, but the Chinese are way behind in drug development and commercialization. That's what I meant.